Biosyent Inc. Cash Flow-to-Debt Ratio
Biosyent Inc. cash flow-to-debt ratio. Biosyent Inc. (RX) has a Cash Flow-to-Debt Ratio of 0.35x as of September 2025, meaning its operating cash flow of CA$2.77 Million could theoretically repay 0% of its total liabilities (CA$7.88 Million) in one year. Check RX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biosyent Inc. (1997–2024)
Cash flow-to-debt ratio of Biosyent Inc. from 1997 to 2024. Historical debt coverage capacity for Biosyent Inc. across 28 annual periods. Check RX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Biosyent Inc. Cash Flow-to-Debt Ratio by Year (1997–2024)
Biosyent Inc. cash flow-to-debt ratio by year from 1997 to 2024. Year-by-year debt coverage analysis for Biosyent Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of Biosyent Inc..
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.36x | CA$8.66 Million | CA$6.36 Million | ▲ +58.4% |
| 2023 | 0.86x | CA$5.83 Million | CA$6.77 Million | ▲ +23.9% |
| 2022 | 0.69x | CA$4.95 Million | CA$7.12 Million | ▼ -16.6% |
| 2021 | 0.83x | CA$4.67 Million | CA$5.61 Million | ▼ -18.1% |
| 2020 | 1.02x | CA$6.89 Million | CA$6.78 Million | ▲ +10.3% |
| 2019 | 0.92x | CA$4.77 Million | CA$5.17 Million | ▼ -47.4% |
| 2018 | 1.75x | CA$6.29 Million | CA$3.58 Million | ▼ -22.5% |
| 2017 | 2.26x | CA$6.55 Million | CA$2.89 Million | ▲ +29.7% |
| 2016 | 1.74x | CA$4.40 Million | CA$2.52 Million | ▲ +52.5% |
| 2015 | 1.14x | CA$2.81 Million | CA$2.46 Million | ▼ -21.9% |
| 2014 | 1.46x | CA$3.64 Million | CA$2.48 Million | ▼ -14.5% |
| 2013 | 1.71x | CA$2.12 Million | CA$1.24 Million | ▲ +11.5% |
| 2012 | 1.54x | CA$1.25 Million | CA$813.36K | ▲ +8.8% |
| 2011 | 1.41x | CA$596.08K | CA$422.37K | ▲ +854.1% |
| 2010 | 0.15x | CA$37.89K | CA$256.17K | ▲ +106.1% |
| 2009 | -2.44x | CA$-342.79K | CA$140.70K | ▼ -164.5% |
| 2008 | -0.92x | CA$-260.09K | CA$282.37K | ▼ -1312.3% |
| 2007 | 0.08x | CA$14.25K | CA$187.53K | ▼ -92.2% |
| 2006 | 0.97x | CA$222.26K | CA$229.20K | ▼ -72.3% |
| 2005 | 3.51x | CA$747.81K | CA$213.28K | ▲ +1150.3% |
| 2004 | -0.33x | CA$-104.39K | CA$312.72K | ▲ +91.1% |
| 2003 | -3.76x | CA$-626.35K | CA$166.53K | ▼ -143.3% |
| 2002 | 8.68x | CA$905.12K | CA$104.22K | ▲ +3363.4% |
| 2001 | -0.27x | CA$-337.40K | CA$1.27 Million | ▼ -103.5% |
| 2000 | -0.13x | CA$-126.07K | CA$964.15K | ▲ +47.7% |
| 1999 | -0.25x | CA$-200.00K | CA$800.00K | ▲ +87.5% |
| 1998 | -2.00x | CA$-1.00 Million | CA$500.00K | ▼ -200.0% |
| 1997 | -0.67x | CA$-400.00K | CA$600.00K | — |